| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:06 | argenx SE: argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference | 1 | GlobeNewswire (USA) | ||
| Mi | Argenx up 7% as rival Biohaven drug study disappoints | 3 | Reuters | ||
| Mi | Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump | 11 | Investor's Business Daily | ||
| 28.05. | Argenx, Hermes, National Grid | 52 | Reuters | ||
| 10.05. | argenx SE (ARGX) Q1 2024 Earnings Call Transcript | 5 | Insider Monkey | ||
| 10.05. | Breaking Down argenx: 12 Analysts Share Their Views | 10 | Benzinga.com | ||
| 09.05. | Argenx shrugs off myasthenia gravis threat from UCB as Vyvgart nears next potential launch | 12 | FiercePharma | ||
| 09.05. | Argenx Posts Wider Than Expected Q1 Loss; Operating Income Climbs | 13 | RTTNews | ||
| 09.05. | Argenx misses top-line and bottom-line estimates; updates FY24 outlook | 9 | Seeking Alpha | ||
| 09.05. | argenx SE: argenx Reports First Quarter 2024 Financial Results and Provides Business Update | 575 | GlobeNewswire (Europe) | $398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second... ► Artikel lesen | |
| 08.05. | ARGENX SE - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 07.05. | argenx SE: argenx announces results of Annual General Meeting of Shareholders | 87 | GlobeNewswire (Europe) | May 7, 2024 - 5:30pm ET Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases... ► Artikel lesen | |
| 07.05. | argenx SE: argenx to Present at BofA Securities 2024 Health Care Conference | 1 | GlobeNewswire (USA) | ||
| 02.05. | argenx SE: argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 | 6 | GlobeNewswire (USA) | ||
| 18.04. | The Analyst Verdict: argenx In The Eyes Of 12 Experts | 13 | Benzinga.com | ||
| 16.04. | With Vyvgart 'firing' in myasthenia gravis, argenx lays launch plans for next potential autoimmune approval: CEO | 9 | FiercePharma | ||
| 16.04. | ARGENX SE - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 16.04. | argenx SE: argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease | 8 | GlobeNewswire (USA) | ||
| 10.04. | Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy | 9 | Benzinga.com | ||
| 27.03. | Plans to pursue efgartigimod development in SjD lift argenx shares | 5 | Reuters |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 6.084 |
| TUI | 4.353 |
| NEL | 4.109 |
| EVOTEC | 3.481 |
| NVIDIA | 2.738 |
| PLUG POWER | 1.856 |
| BAYER | 1.754 |
| BYD | 1.660 |
| BIONTECH | 1.437 |
| VOLKSWAGEN | 1.215 |
| RHEINMETALL | 1.200 |
| DEUTSCHE LUFTHANSA | 1.067 |
| SUPER MICRO COMPUTER | 1.042 |
| DEUTSCHE TELEKOM | 1.033 |
| AIXTRON SE | 848 |
| AMC ENTERTAINMENT | 831 |
| ALLIANZ | 753 |
| DEUTSCHE BANK | 725 |
| RWE | 710 |
| AMD | 689 |
| BASF | 688 |
| JINKOSOLAR | 654 |
| COMMERZBANK | 653 |
| SIEMENS ENERGY | 643 |
| MERCEDES-BENZ | 637 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
